welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
Cardiac Outcome Measures in Children With Muscular Dystrophy
study id #: NCT01066455
condition: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy
The purpose of the research study is to evaluate different cardiac measures that are obtained by echocardiographic tests in patients with muscular dystrophy.
mechanism of action: No pharmaceutical intervention
last updated: November 22, 2018
start date: January 2010
estimated completion: May 2012
size / enrollment: 48
The research study will include 50 participants aged 8 to 18 years old (before 18th birthday) with Duchenne, Becker, or autosomal recessive limb-girdle (specifically: LGMD 2C-2F and 2I) muscular dystrophies.
Participants will be seen in one of five Cooperative International Neuromuscular Research Group (CINRG) centers located in the United States.
All study assessments will be completed in the same day and include reviewing past medical and surgical history, collecting vital signs, collecting cardiac measures through echocardiographic tests.
• Participants must be between the ages of 8 and 18 years old
• Confirmed diagnosis of muscular dystrophy (DMD, BMD, or LGMD 2C-2F and 2I)
• Investigator assessment of inability to comply with protocol • History of a congenital cardiac defect or other cardiac disease unrelated to muscular dystrophy
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic TomographyThis pilot study aims to assess subcellu...
(-)- Epicatechin Becker Muscular DystrophyThis is a 48-week open-label extension o...
Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular DystrophyDystrophinopathy is a disease continuum ...
Santhera to present novel data highlighting the clinical relevance of peak expiratory flow as predictor of disease p...Santhera Pharmaceuticals announces that ...
Biomechanical and Morphological Changes in Dystrophic MuscleThe loss of ability to walk in many chil...
Analysis of a Virtual Reality Task in Patients With Duchenne Muscular DystrophyThe task consists in reach as much bubbl...
Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)The primary objective of this Expanded A...
Digital Droplet PCR for the Absolute Quantification of Exon Skipping Induced by Antisense Oligonucleotides in (Pre-)...Antisense oligonucleotides (AONs) in cli...
Brief Overview: Duchenne Muscular Dystrophyhttps://www.slideshare.net/visprod/duche...
PTC Therapeutics Phase III Duchenne Muscular Dystrophy (DMD) Clinical TrialPTC Therapeutics, Inc. is seeking pa...
Antisense Therapeutics to commence muscular dystrophy trialsAntisense Therapeutics is planning to un...